137 related articles for article (PubMed ID: 9631579)
21. Serum erythropoietin levels and their correlation with the erythropoietic system in hemodialysis patients and renal allograft recipients.
Khosroshahi HT; Shoja MM; Tubbs RS; Estakhri R; Ardalan MR
Transplant Proc; 2007 May; 39(4):1051-3. PubMed ID: 17524889
[TBL] [Abstract][Full Text] [Related]
22. Markedly increased serum erythropoietin levels following conditioning for allogeneic bone marrow transplantation.
Abedi MR; Bäckman L; Boström L; Lindbäck B; Ringdén O
Bone Marrow Transplant; 1990 Aug; 6(2):121-6. PubMed ID: 2207449
[TBL] [Abstract][Full Text] [Related]
23. [Successful treatment of prolonged anemia after major ABO incompatible bone marrow transplantation for a case of myelodysplastic syndrome with recombinant erythropoietin].
Koda K; Hayashi S; Ikeda K; Morita K; Tsuji Y; Takimoto R; Fujisaki Y; Nakazawa O
Rinsho Ketsueki; 1992 Jul; 33(7):991-3. PubMed ID: 1507422
[TBL] [Abstract][Full Text] [Related]
24. Frequency of administration of recombinant human erythropoietin for anaemia of end-stage renal disease in dialysis patients.
Cody J; Daly C; Campbell M; Donaldson C; Grant A; Khan I; Vale L; Wallace S; MacLeod A
Cochrane Database Syst Rev; 2002; (4):CD003895. PubMed ID: 12519614
[TBL] [Abstract][Full Text] [Related]
25. Dynamics of erythropoietic recovery following bone marrow transplantation: role of marrow proliferative capacity and erythropoietin production in autologous versus allogeneic transplants.
Beguin Y; Oris R; Fillet G
Bone Marrow Transplant; 1993 Apr; 11(4):285-92. PubMed ID: 8485476
[TBL] [Abstract][Full Text] [Related]
26. The impact of pretransplant erythropoietin therapy on late outcomes of renal transplantation.
Lietz K; Lao M; Paczek L; Górski A; Gaciong Z
Ann Transplant; 2003; 8(2):17-24. PubMed ID: 14626572
[TBL] [Abstract][Full Text] [Related]
27. Recombinant human erythropoietin in the treatment of multiple myeloma-associated anemia.
Mittelman M; Zeidman A; Fradin Z; Magazanik A; Lewinski UH; Cohen A
Acta Haematol; 1997; 98(4):204-10. PubMed ID: 9401498
[TBL] [Abstract][Full Text] [Related]
28. Reduced blood transfusions requirements after allogeneic bone marrow transplantation: results of a randomised, double-blind study with high-dose erythropoietin.
Klaesson S; Ringdén O; Ljungman P; Lönnqvist B; Wennberg L
Bone Marrow Transplant; 1994 Apr; 13(4):397-402. PubMed ID: 8019463
[TBL] [Abstract][Full Text] [Related]
29. Successful treatment of refractory anemia with a combination regimen containing recombinant human erythropoietin, low-dose methylprednisolone and nandrolone.
Tsiara SN; Chaidos A; Gouva M; Christou L; Panteli K; Kapsali E; Bourantas KL
J Exp Clin Cancer Res; 2004 Mar; 23(1):47-52. PubMed ID: 15149150
[TBL] [Abstract][Full Text] [Related]
30. Clinical use of rHuEPO in bone marrow transplantation.
Klaesson S
Med Oncol; 1999 Apr; 16(1):2-7. PubMed ID: 10382935
[TBL] [Abstract][Full Text] [Related]
31. A comparison of related donor peripheral blood and bone marrow transplants: importance of late-onset chronic graft-versus-host disease and infections.
Anderson D; DeFor T; Burns L; McGlave P; Miller J; Wagner J; Weisdorf D
Biol Blood Marrow Transplant; 2003 Jan; 9(1):52-9. PubMed ID: 12533742
[TBL] [Abstract][Full Text] [Related]
32. [Treatment of anemia in chronic hemodialysis patients with recombinant human erythropoietin: long-term results in 15 patients].
Jacquot C; Berthelot JM; Chiappini-Judith D; Ferragu-Haguet M; Lefebvre A; Masselot JP; Moynot A; Frydman MO; Peterlongo F
Nephrologie; 1990; 11(1):11-6. PubMed ID: 2374641
[TBL] [Abstract][Full Text] [Related]
33. Retrospective observational study of patients with chemotherapy-related anemia receiving erythropoietic agents.
Mark TL; McKenzie RS; Fastenau J; Piech CT
Curr Med Res Opin; 2005 Sep; 21(9):1347-54. PubMed ID: 16197652
[TBL] [Abstract][Full Text] [Related]
34. [Treatment of anemia with recombinant human erythropoietin and the bone marrow response in uremic patients undergoing periodic hemodialysis].
García Martín F; Carrascosa Vallejo T; Martín Escobar E; Val Begueria J; Martín Hernández R; de Arriba G; Teno C; Salvatierra J
Rev Clin Esp; 1990 May; 186(9):419-22. PubMed ID: 2247677
[TBL] [Abstract][Full Text] [Related]
35. Use of recombinant human erythropoietin as an antianemic and performance enhancing drug.
Jelkmann W
Curr Pharm Biotechnol; 2000 Jul; 1(1):11-31. PubMed ID: 11467358
[TBL] [Abstract][Full Text] [Related]
36. Serum erythropoietin levels in allogeneic, non T-depleted bone marrow transplantation, and the effects of rhEpo administration.
Bosi A; Vannucchi AM; Grossi A; Guidi S; Rafanelli D; Saccardi R; Ferrini PR
Bone Marrow Transplant; 1991; 7 Suppl 2():87. PubMed ID: 1878736
[No Abstract] [Full Text] [Related]
37. Effect of recombinant human erythropoietin on anticancer drug-induced anaemia.
Matsumoto T; Endoh K; Kamisango K; Akamatsu K; Koizumi K; Higuchi M; Imai N; Mitsui H; Kawaguchi T
Br J Haematol; 1990 Aug; 75(4):463-8. PubMed ID: 2206997
[TBL] [Abstract][Full Text] [Related]
38. Recombinant human erythropoietin for the correction of cancer associated anemia with and without concomitant cytotoxic chemotherapy.
Ludwig H; Sundal E; Pecherstorfer M; Leitgeb C; Bauernhofer T; Beinhauer A; Samonigg H; Kappeler AW; Fritz E
Cancer; 1995 Dec; 76(11):2319-29. PubMed ID: 8635038
[TBL] [Abstract][Full Text] [Related]
39. [Effect of the treatment with human recombinant erythropoietin on anemia in children with end-stage kidney failure. French multicenter study].
Sinnassamy P; Andre JL; Treize G; Leroy B
Arch Fr Pediatr; 1993 Mar; 50(3):201-8. PubMed ID: 8338412
[TBL] [Abstract][Full Text] [Related]
40. Clinical and in vitro effects of recombinant human erythropoietin in patients receiving intensive chemotherapy for small-cell lung cancer.
de Campos E; Radford J; Steward W; Milroy R; Dougal M; Swindell R; Testa N; Thatcher N
J Clin Oncol; 1995 Jul; 13(7):1623-31. PubMed ID: 7602351
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
